LOM Asset Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.91M Buy
7,594
+235
+3% +$50.6K 0.49% 72
2026
Q1
$1.6M Buy
7,359
+125
+2% +$27.7K 0.46% 76
2025
Q4
$1.65M Sell
7,234
-133
-2% -$30.3K 0.48% 71
2025
Q3
$1.71M Sell
7,367
-105
-1% -$21.4K 0.52% 66
2025
Q2
$1.39M Buy
+7,472
New +$1.39M 0.47% 69

Other funds holding ABBV

LOM Asset Management's ABBV Position: Q2 2026 in Review

LOM Asset Management increased its AbbVie (ABBV) stake by 3.2% in Q2 2026, buying an estimated $50.6K and bringing the position to 7,594 shares worth $1.91M. The position accounts for 0.49% of the portfolio, ranked #72.

LOM Asset Management first reported a position in ABBV in Q2 2025 and has held it in 5 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • LOM Asset Management held 7,594 shares of AbbVie worth $1.91M as of Q2 2026.
  • LOM Asset Management bought 235 AbbVie shares in Q2 2026, an estimated $50.6K.
  • AbbVie made up 0.49% of LOM Asset Management's portfolio in Q2 2026, its #72 holding.
  • LOM Asset Management first reported a position in AbbVie in Q2 2025 and has held it in 5 quarters since.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on LOM Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.